Achieve Life Sciences, Inc.
ACHV· Nasdaq
Filed May 3, 2012 · 10-Q · 33 days after period end · 0001193125-12-208535
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Net Income | -$6.86M | -$3.05M |
| EPS Diluted | -$0.67 | -$0.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 3, 2012 · 33 d after period end